Computational fragment-based approach at PDB scale by protein local similarity

Journal of Chemical Information and Modeling

Volumn 49, Issue 2, 2009, Pages 280-294

  Moriaud, Fabrice ^a   Doppelt Azeroual, Olivia ^a   Martin, Laetitia ^a   Oguievetskaia, Ksenia ^a   Koch, Kerstin ^b   Vorotyntsev, Artem ^a   Adcock, Stewart A ^a   Delfaud, François ^a  

^a MEDIT SA   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYMES; LIGANDS; MOLECULES; QUERY PROCESSING;

EFFICIENT PROTOCOLS; G-PROTEIN COUPLED RECEPTORS; LOCAL SIMILARITY; PROTEIN 3-D STRUCTURE; PROTEIN INTERACTION; PROTEIN-BINDING SITES; PROTEIN-LIGAND STRUCTURES; STRUCTURAL OBJECTS;

BINDING SITES;

LIGAND; PEPTIDE FRAGMENT; PROTEIN;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; PROTEIN BINDING; PROTEIN DATABASE; VALIDATION STUDY;

DATABASES, PROTEIN; LIGANDS; MODELS, MOLECULAR; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEINS;

EID: 65249116422     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci8003094     Document Type: Article

References (75)

1. Berman, H. M.; Westbrook, J.; Feng, Z.; Gilliland, G.; Bhat, T. N.; Weissig, H.; Shindyalov, I. N.; Bourne, P. E. The Protein Data Bank. Nucleic Acids Res. 2000, 28, 235-42.
2. Allen, K. N.; Bellamacina, C. R.; Xiaochung, D.; Jeffery, C. J.; Mattos, C.; Petsko, G. A.; Ringe, D. An experimental approach to mapping the binding surfaces of crystalline proteins. J. Phys. Chem. 1996, 100, 2605-2611.
3. Erlanson, D. A. Fragment-based ligand discovery meets phage display. ACS Chem. Biol. 2007, 2, 779-82.
4. Jahnke, W. Perspectives of biomolecular NMR in drug discovery: the blessing and curse of versatility. J. Biomol. NMR 2007, 39, 87-90.
5. Leach, A. R.; Hann, M. M.; Burrows, J. N.; Griffen, E. J. Fragment screening: an introduction. Mol. Biosyst. 2006, 2, 430-46.
6. Congreve, M.; Murray, C. W.; Blundell, T. L. Structural biology and drug discovery. Drug Discovery Today 2005, 10, 895-907.
7. Shuker, S. B.; Hajduk, P. J.; Meadows, R. P.; Fesik, S. W. Discovering high-affinity ligands for proteins: SAR by NMR. Science 1996, 274, 1531-4.
8. Chilli, A.; Williams, G.; Smith, A. G.; Blundell, T. L.; Abell, C. Probing hot spots at protein-ligand binding sites: a fragment-based approach using biophysical methods. J. Med. Chem. 2006, 49, 4992-5000.
9. Verlinde, C. L. M. J., Kim, H., Bernstein, B. E., Mande, S. C.; Hol, W. G. J. Antitrypanosomiasis drug development based on structures of glycolytic enzymes. In Structure-Based Drug Design; Veerapandian, P., Ed.; Marcel Dekker: New York, 1997; pp 365-394.
10. Saxty, G.; Woodhead, S. J.; Berdini, V.; Davies, T. G.; Verdonk, M. L.; Wyatt, P. G.; Boyle, R. G.; Barford, D.; Downham, R.; Garrett, M. D.; Carr, R. A. Identification of inhibitors of protein kinase B using fragment-based lead discovery. J. Med. Chem. 2007, 50, 2293-6.
11. Hajduk, P. J.; Greer, J. A decade of fragment-based drug design: strategic advances and lessons learned. Nat. Rev. Drug Discovery 2007, 6, 211-9.
12. Kortvelyesi, T.; Dennis, S.; Silberstein, M.; Brown, L.; Vajda, S. Algorithms for computational solvent mapping of proteins. Proteins 2003, 51, 340-51.
13. Cummings, M. D.; DesJarlais, R. L.; Gibbs, A. C.; Mohan, V.; Jaeger, E. P. Comparison of automated docking programs as virtual screening tools. J. Med. Chem. 2005, 48, 962-76.
14. Bohm, H. J. A novel computational tool for automated structure-based drug design. J. Mol. Recognit. 1993, 6, 131-7.
15. Schneider, G.; Fechner, U. Computer-based de novo design of druglike molecules. Nat. Rev. Drug Discovery 2005, 4, 649-63.
16. Goodford, P. J. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. J. Med. Chem. 1985, 28, 849-57.
17. Miranker, A.; Karplus, M. Functionality maps of binding sites: a multiple copy simultaneous search method. Proteins 1991, 11, 29-34.
18. Evensen, E.; Joseph-McCarthy, D.; Weiss, G. A.; Schreiber, S. L.; Karplus, M. Ligand design by a combinatorial approach based on modeling and experiment: application to HLA-DR4. J. Comput.-Aided Mol. Des 2007, 21, 395-418.
19. Deng, Z.; Chuaqui, C.; Singh, J. Structural interaction fingerprint (SIFt): a novel method for analyzing three-dimensional protein-ligand binding interactions. J. Med. Chem. 2004, 47, 337-44.
20. Pierce, A. C.; Rao, G.; Bemis, G. W. BREED: Generating novel inhibitors through hybridization of known ligands. Application to CDK2, p38, and HIV protease. J. Med. Chem. 2004, 47, 2768-75.
21. Schmitt, S.; Kuhn, D.; Klebe, G. A new method to detect related function among proteins independent of sequence and fold homology. J. Mol. Biol. 2002, 323, 387-406.
22. Artymiuk, P. J.; Poirrette, A. R.; Grindley, H. M.; Rice, D. W.; Willett, P. A graph-theoretic approach to the identification of three-dimensional patterns of amino acid side-chains in protein structures. J. Mol. Biol. 1994, 243, 327-44.
23. Wallace, A. C.; Borkakoti, N.; Thornton, J. M. TESS: a geometric hashing algorithm for deriving 3D coordinate templates for searching structural databases. Application to enzyme active sites. Protein Sci. 1997, 6, 2308-23.
24. Jambon, M.; Imberty, A.; Deleage, G.; Geourjon, C. A new bioinformatic approach to detect common 3D sites in protein structures. Proteins 2003, 52, 137-45.
25. Barker, J. A.; Thornton, J. M. An algorithm for constraint-based structural template matching: application to 3D templates with statistical analysis. Bioinformatics 2003, 19, 1644-9.
26. Stark, A.; Sunyaev, S.; Russell, R. B. A model for statistical significance of local similarities in structure. J. Mol. Biol. 2003, 326, 1307-16.
27. Shulman-Peleg, A.; Nussinov, R.; Wolfson, H. J. SiteEngines: recognition and comparison of binding sites and protein-protein interfaces. Nucleic Acids Res. 2005, 33, W337-41.
28. Gold, N. D.; Jackson, R. M. Fold independent structural comparisons of protein-ligand binding sites for exploring functional relationships. J. Mol. Biol. 2006, 355, 1112-24.
29. Ramensky, V.; Sobol, A.; Zaitseva, N.; Rubinov, A.; Zosimov, V. A novel approach to local similarity of protein binding sites substantially improves computational drug design results. Proteins 2007, 69, 349-57.
30. Lewell, X. Q.; Judd, D. B.; Watson, S. P.; Hann, M. M. RECAP-retrosynthetic combinatorial analysis procedure: a powerful new technique for identifying privileged molecular fragments with useful applications in combinatorial chemistry. J. Chem. Inf. Comput. Sci. 1998, 38, 511-22.
31. Jambon, M.; Andrieu, O.; Combet, C.; Deleage, G.; Delfaud, F.; Geourjon, C. The SuMo server: 3D search for protein functional sites. Bioinformatics 2005, 21, 3929-30.
32. Doppelt, O.; Moriaud, F.; Bornot, A.; de Brevern, A. G. Functional annotation strategy for protein structures. Bioinformation 2007, 1, 357-9.
33. Jambon, M. A bioinformatic system for searching functional similarities in 3D structures of proteins; Univevsité Claude Bernard Lyon 1, 2003.
34. Release of remediated PDB archive. ftp://ftp.wwpdb.org/ (accessed July 16, 2008).
35. Guha, R.; Howard, M. T.; Hutchison, G. R.; Murray-Rust, P.; Rzepa, H.; Steinbeck, C.; Wegner, J.; Willighagen, E. L. The Blue Obeliskinteroperability in chemical informatics. J. Chem. Inf. Model 2006, 46, 991-8.
36. The Open Babel Package. http://openbabel.sourceforge.net/ (accessed July 5, 2008).
37. CTFile Formats. www.mdl.com/downloads/public/ctfile/ctfile.pdf (accessed November 1, 2007).
38. The PubChem Project. http://pubchem.ncbi.nlm.nih.gov (accessed June 9, 2008).
39. SQLite. http://oandrieu.nerim.net/ocaml/mlsqlite/ (accessed October 26, 2008).
40. Hasegawa, M.; Nishigaki, N.; Washio, Y.; Kano, K.; Harris, P. A.; Sato, H.; Mori, I.; West, R. I.; Shibahara, M.; Toyoda, H.; Wang, L.; Nolte, R. T.; Veal, J. M.; Cheung, M. Discovery of novel benzimi-dazoles as potent inhibitors of TIE-2 and VEGFR-2 tyrosine kinase receptors. J. Med. Chem. 2007, 50, 4453-70.
41. Ghosh, A. K.; Devasamudram, T.; Hong, L.; DeZutter, C.; Xu, X.; Weerasena, V.; Koelsch, G.; Bilcer, G.; Tang, J. Structure-based design of cycloamide-urethane-derived novel inhibitors of human brain memapsin 2 (beta-secretase). Bioorg. Med. Chem. Lett. 2005, 15, 15-20.
42. Scitegic Pipeline Pilot, 7.0; Accelrys Software Inc.: 10188 Telesis Court, S.S.D., CA 92121, U.S.A., 2004-2008.
43. MOE; Chemical Computing Group Inc.: 1010 Sherbrooke St. W, S.M., Quebec, Canada H3A 2R7, 2003-2004.
44. Weininger, D. SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules. J. Chem. Inf. Comput. Sci. 1988, 28, 31-36.
45. Weininger, D. SMILES. 2. Algorithm for generation of unique SMILES notation. J. Chem. Inf. Comput. Sci. 1989, 29, 97-101.
46. Finn, R. D.; Tate, J.; Mistry, J.; Coggill, P. C.; Sammut, S. J.; Hotz, H. R.; Ceric, G.; Forslund, K.; Eddy, S. R.; Sonnhammer, E. L.; Bateman, A. The Pfam protein families database. Nucleic Acids Res. 2008, 36, D281-8.
47. Discovery Studio, 2.0; Accelrys Software Inc.: 10188 Telesis Court, S.S.D., CA 92121, U.S.A., 2005-2007.
48. Hopkins, A. L.; Groom, C. R.; Alex, A. Ligand efficiency: a useful metric for lead selection. Drug Discovery Today 2004, 9, 430-1.
49. Cherezov, V.; Rosenbaum, D. M.; Hanson, M. A.; Rasmussen, S. G.; Thian, F. S.; Kobilka, T. S.; Choi, H. J.; Kuhn, P.; Weis, W. I.; Kobilka, B. K.; Stevens, R. C. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 2007, 318, 1258-65.
50. Bemis, G. W.; Murcko, M. A. The properties of known drugs. 1. Molecular frameworks. J. Med. Chem. 1996, 39, 2887-93.
51. Daylight fingerprints. http://www.daylight.com/dayhtml/doc/theory/ theory.finger.html (accessed November 1, 2007).
52. Tanimoto, T. T. IBM Internal Report 17th Nov.; IBM: 1957.
53. Gao, Z.; Li, H.; Zhang, H.; Liu, X.; Kang, L.; Luo, X.; Zhu, W.; Chen, K.; Wang, X.; Jiang, H. PDTD: a web-accessible protein database for drug target identification. BMC Bioinf. 2008, 9, 104.
54. Laurie, A. T.; Jackson, R.M. Q-SiteFinder: an energy-based method for the prediction of protein-ligand binding sites. Bioinformatics 2005, 21, 1908-16.
55. Congreve, M.; Carr, R.; Murray, C.; Jhoti, H. A 'rule of three' for fragmentbased lead discovery. Drug Discovery Today 2003, 8, 876-7.
56. Taylor, S. S.; Radzio-Andzelm, E. Protein kinase inhibition: natural and synthetic variations on a theme. Curr. Opin. Chem. Biol. 1997, 1, 219-26.
57. Bossemeyer, D. Protein kinases-structure and function. FEBS Lett. 1995, 369, 57-61.
58. Levitzki, A. Protein kinase inhibitors as a therapeutic modality. Acc. Chem. Res. 2003, 36, 462-9.
59. Fabbro, D.; Garcia-Echeverria, C. Targeting protein kinases in cancer therapy. Curr. Opin. Drug Discovery Dev. 2002, 5, 701-12.
60. Nagar, B.; Bornmann, W. G.; Pellicena, P.; Schindler, T.; Veach, D. R.; Miller, W. T.; Clarkson, B.; Kuriyan, J. Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571). Cancer Res. 2002, 62, 4236-43.
61. Atwell, S.; Adams, J. M.; Badger, J.; Buchanan, M. D.; Feil, I. K.; Froning, K. J.; Gao, X.; Hendle, J.; Keegan, K.; Leon, B. C.; Muller-Dieckmann, H. J.; Nienaber, V. L.; Noland, B. W.; Post, K.; Rajashankar, K. R.; Ramos, A.; Russell, M.; Burley, S. K.; Buchanan, S. G. A novel mode of Gleevec binding is revealed by the structure of spleen tyrosine kinase. J. Biol. Chem. 2004, 279, 55827-32.
62. Huang, N.; Shoichet, B. K.; Irwin, J. J. Benchmarking sets for molecular docking. J. Med. Chem. 2006, 49, 6789-801.
63. Schroeder, G. M.; Chen, X. T.; Williams, D. K.; Nirschl, D. S.; Cai, Z. W.; Wei, D.; Tokarski, J. S.; An, Y.; Sack, J.; Chen, Z.; Huynh, T.; Vaccaro, W.; Poss, M.; Waudet, B.; Gullo-Brown, J.; Kellar, K.; Manne, V.; Hunt, J. T.; Wong, T. W.; Lombardo, L. J.; Fargnoli, J.; Borzilleri, R. M. Identification of pyrrolo[2,l-f][l,2,4]triazine-based inhibitors of Met kinase. Bioorg. Med. Chem. Lett. 2008, 18, 1945-51.
64. Lagerstrom, M. C.; Schioth, H. B. Structural diversity of G proteincoupled receptors and significance for drug discovery. Nat. Rev. Drug Discovery 2008, 7, 339-57.
65. Pierce, K. L.; Premont, R. T.; Lefkowitz, R. J. Seven-transmembrane receptors. Nat. Rev. Mol. Cell Biol. 2002, 3, 639-50.
66. Lefkowitz, R. J.; Rajagopal, K.; Whalen, E. J. New roles for betaarrestins in cell signaling: not just for seven-transmembrane receptors. Mol. Cell 2006, 24, 643-52.
67. Bjarnadottir, T. K.; Gloriam, D. E.; Hellstrand, S. H.; Kristiansson, H.; Fredriksson, R.; Schioth, H. B. Comprehensive repertoire and phylogenetic analysis of the G protein-coupled receptors in human and mouse. Genomics 2006, 88, 263-73.
68. Filmore, D. It's a GPCR world. ACS Modern Drug Discovery 2004, 7, 24-28.
69. Palczewski, K.; Kumasaka, T.; Hori, T.; Behnke, C. A.; Motoshima, H.; Fox, B. A.; Le Trong, I.; Teller, D. C.; Okada, T.; Stenkamp, R. E.; Yamamoto, M.; Miyano, M. Crystal structure of rhodopsin: A G protein-coupled receptor. Science 2000, 289, 739-45.
70. Salom, D.; Lodowski, D. T.; Stenkamp, R. E.; Le Trong, I.; Golczak, M.; Jastrzebska, B.; Harris, T.; Ballesteros, J. A.; Palczewski, K. Crystal structure of a photoactivated deprotonated intermediate of rhodopsin. Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 16123-8.
71. Rasmussen, S. G.; Choi, H. J.; Rosenbaum, D. M.; Kobilka, T. S.; Thian, F. S.; Edwards, P. C.; Burghammer, M.; Ratnala, V. R.; Sanishvili, R.; Fischetti, R. F.; Schertler, G. F.; Weis, W. I.; Kobilka, B. K. Crystal structure of the human beta2 adrenergic G-proteincoupled receptor. Nature 2007, 450, 383-7.
72. Hanson, M. A.; Cherezov, V.; Griffith, M. T.; Roth, C. B.; Jaakola, V. P.; Chien, E. Y.; Velasquez, J.; Kuhn, P.; Stevens, R. C. A specific cholesterol binding site is established by the 2.8 A structure of the human beta2-adrenergic receptor. Structure 2008, 16, 897-905.
73. Warne, T.; Serrano-Vega, M. J.; Baker, J. G.; Moukhametzianov, R.; Edwards, P. C.; Henderson, R.; Leslie, A. G.; Tate, C. G.; Schertler, G. F. Structure of a betal-adrenergic G-protein-coupled receptor. Nature 2008, 454, 486-91.
74. Topiol, S.; Sabio, M. Use of the X-ray structure of the Beta2-adrenergic receptor for drug discovery. Bioorg. Med. Chem. Lett. 2008, 18, 1598-602.
75. Rosenbaum, D. M.; Cherezov, V.; Hanson, M. A.; Rasmussen, S. G.; Thian, F. S.; Kobilka, T. S.; Choi, H. J.; Yao, X. J.; Weis, W. I.; Stevens, R. C.; Kobilka, B. K. GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function. Science 2007, 318, 1266-73.